Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124040635 | 12404063 | 5 | F | 20140919 | 20160818 | 20160525 | 20160823 | EXP | US-GLAXOSMITHKLINE-US2016GSK073339 | GLAXOSMITHKLINE | 50.72 | YR | F | Y | 0.00000 | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124040635 | 12404063 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | UNK UNK, U | U | UNKNOWN | 20241 | |||||||||
| 124040635 | 12404063 | 2 | SS | LAMICTAL XR | LAMOTRIGINE | 1 | 200 MG, U | U | UNKNOWN | 0 | 200 | MG | PROLONGED-RELEASE TABLET | ||||||
| 124040635 | 12404063 | 3 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | UNK UNK, U | U | 20241 | TABLET | |||||||||
| 124040635 | 12404063 | 4 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | 200 MG | U | 20241 | TABLET | |||||||||
| 124040635 | 12404063 | 5 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | 50 MG | U | 20241 | TABLET | |||||||||
| 124040635 | 12404063 | 6 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | UNK UNK, U | U | UNKNOWN | 20241 | TABLET | ||||||||
| 124040635 | 12404063 | 7 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | UNK | U | 0 | DISPERSIBLE TABLET | |||||||||
| 124040635 | 12404063 | 8 | SS | KEPPRA | LEVETIRACETAM | 1 | U | 0 | |||||||||||
| 124040635 | 12404063 | 9 | SS | DILANTIN | PHENYTOIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124040635 | 12404063 | 1 | Seizure |
| 124040635 | 12404063 | 2 | Seizure |
| 124040635 | 12404063 | 3 | Epilepsy |
| 124040635 | 12404063 | 4 | Seizure |
| 124040635 | 12404063 | 7 | Epilepsy |
| 124040635 | 12404063 | 8 | Epilepsy |
| 124040635 | 12404063 | 9 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124040635 | 12404063 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124040635 | 12404063 | Anxiety | |
| 124040635 | 12404063 | Brain operation | |
| 124040635 | 12404063 | Breast cancer | |
| 124040635 | 12404063 | Disturbance in attention | |
| 124040635 | 12404063 | Drug effect incomplete | |
| 124040635 | 12404063 | Drug ineffective | |
| 124040635 | 12404063 | Epilepsy | |
| 124040635 | 12404063 | Ill-defined disorder | |
| 124040635 | 12404063 | Loss of consciousness | |
| 124040635 | 12404063 | Seizure | |
| 124040635 | 12404063 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124040635 | 12404063 | 1 | 2004 | 0 | ||
| 124040635 | 12404063 | 2 | 2005 | 0 | ||
| 124040635 | 12404063 | 3 | 2010 | 0 | ||
| 124040635 | 12404063 | 4 | 2011 | 0 | ||
| 124040635 | 12404063 | 5 | 2011 | 0 | ||
| 124040635 | 12404063 | 7 | 201602 | 0 |